Atlas Trials

The Real-world Study of AK104 Combining With TACE for Resectable Hepatocellular Carcinoma (MORNING)

Clinical trial NCT07064681 · RECRUITING

Trial details

NCT number
NCT07064681
Sponsor
Sun Yat-sen University
Status
RECRUITING
Study type
OBSERVATIONAL
Resectable Hepatocellular Carcinoma With High Risk of Recurrence
Start date
2025-07-05
Primary completion
2025-12-17
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.